Cargando…
微转移在非小细胞肺癌的预后价值
Lung cancer ranks top in morbidity and mortality among the malignancies in China. Non-small cell lung cancer (NSCLC) accounts for about 80%-85% of all lung malignancies. The stage at diagnosis is the principal prognostic indicator, and accurate staging is essential for treatment decisions. After rad...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000635/ https://www.ncbi.nlm.nih.gov/pubmed/24034998 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.09.10 |